ArticleFrontiers in oncology2026
Case Report: Phosphaturic mesenchymal tumor of the scapula without calcification: a potential diagnostic pitfall.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Phosphaturic mesenchymal tumor (PMT) is extremely rare, yet it is the most common cause of tumor-induced hypophosphatemic osteomalacia (TIO). Accurate histopathological diagnosis is critical for treatment. Nevertheless, its rarity and variable histomorphology make the diagnosis highly challenging. Notably, grungy calcification serves as a key morphological diagnostic clue for PMT. Case description: Herein, we report a case of a 57-year-old female patient who presented with a three-year history of recurrent bone pain. Laboratory investigations revealed hypophosphatemia. Whole-body positron emission tomography/computed tomography (PET/CT) showed an osteolytic lesion in the scapula. Biopsy demonstrated tumor cells arranged in a patchy pattern around the bone trabeculae and intermingled with mature adipose tissue. Myxoid degeneraty -30ion was observed in the stroma, but no calcification was identified. Immunohistochemically, the tumor cells expressed SATB2, SSTR2A, ERG, and CD56. The diagnosis of scapular PMT was ultimately established based on histopathological, clinical, and laboratory correlations, and the postoperative course showed substantial relief of bone pain and a progressive increase in serum phosphorus, which strongly reinforced this diagnosis. Conclusions: We report an unusual case of PMT arising in the scapula, characterized by the absence of calcification, which initially made the histopathological diagnosis elusive. This case highlights that pathologists must integrate clinical and laboratory findings, as these often provide greater diagnostic value than morphology alone, underscoring the importance of a multidisciplinary approach in diagnosing rare tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.